This site is intended for healthcare professionals

Sign in
Go to /sign-in page

You can view 5 more pages before signing in

Prognosis

Last reviewed dd mmm yyyy. Last edited dd mmm yyyy

Authoring team

Irritable bowel syndrome (IBS) is a benign condition and has an excellent long-term prognosis.

A prospective study regarding prognosis in IBS revealed (1):

  • 85% of patients were rendered virtually symptom-free in the short term
  • 68% were still virtually symptom-free 5 years later
  • response to treatment was better in men than in women, in those with constipation than with diarrhoea, when the symptoms had initially been triggered by an episode of acute diarrhoea, and in patients with a relatively short history
  • the authors noted that the response to treatment was considerably better than expected, possibly because of the more aggressive use of high-fibre diets and bulking agents

A more recent questionnaire based study (2) concluded that:

  • less than 50% of both post-infective-IBS and non-infective IBS cases recover over six years

Reference:

  1. Harvey RF et al (1987). Prognosis in the irritable bowel syndrome: a 5-year prospective study. Lancet;1(8539):963-5
  2. Neal KR et al (2002). Prognosis in post-infective irritable bowel syndrome: a six year follow up study. Gut ;51(3):410-3

Create an account to add page annotations

Create a free account

Annotations allow you to add information to this page that would be handy to have on hand during a consultation. E.g. a website or number. This information will always show when you visit this page.

The content herein is provided for informational purposes and does not replace the need to apply professional clinical judgement when diagnosing or treating any medical condition. A licensed medical practitioner should be consulted for diagnosis and treatment of any and all medical conditions.

Connect

Copyright 2024 Oxbridge Solutions Limited, a subsidiary of OmniaMed Communications Limited. All rights reserved. Any distribution or duplication of the information contained herein is strictly prohibited. Oxbridge Solutions receives funding from advertising but maintains editorial independence.